<DOC>
	<DOCNO>NCT02983422</DOCNO>
	<brief_summary>This study evaluate effect aminophylline serum creatinine urine volume AKI Patient.Half participant receive aminophylline furosemide combination , half receive furosemide .</brief_summary>
	<brief_title>Effects Aminophylline Renal Function Urine Volume AKI Patient</brief_title>
	<detailed_description>Acute kidney injury ( AKI ) sudden perturbation kidney function frequently associate high morbidity mortality rate . A diagnostic time limit 48 hour recently introduce ensure early diagnosis , management prevention progression irreversible renal function loss . Furthermore , early AKI biomarkers ensure prompt diagnosis identify . When biomarkers become widely available clinical practice , inform therapeutic intervention capable abort disease progression , morbidity mortality multiplication apply . In injured kidney , adenosine release endogenously macula densa cause vasoconstriction renal afferent arteriole via adenosine A1receptor well vasodilatation renal efferent arteriole via adenosine A2 receptor ; thereby reduce renal blood flow glomerular perfusion pressure lead ischemic kidney injury . One measure try objective achieve good AKI outcome use aminophylline ( ethylenediamine couple theophylline ) . Aminophylline convert theophylline human body , turn vasodilates renal afferent arteriole competitive inhibition adenosine adenosine A1 receptor . Aminophylline theophylline , methylxanthine nonselective adenosine receptor antagonist , effective management AKI certain clinical scenario include heart failure , calcineurin inhibitor toxicity , perinatal asphyxia . In kidney , adenosine constricts afferent arteriole decrease glomerular blood flow ; adenosine receptor blockade mitigate vasoconstriction . Aminophylline also inhibit phosphodiesterase high concentration , lead increase urine output . Eligible subject include patient 18 year old acute kidney injury ICU . To ensure safe oversight duration study drug infusion , investigator approach patient consent participant ' ICU stay would likely least 72 hour . Patients recruit preoperative clinic inpatient ward/ICU ; nature consent process interventional drug trial necessitate procedure elective schedule . Because aminophylline associate tachycardia seizure high serum level , metabolism may affect liver thyroid dysfunction sepsis , investigator select follow exclusion criterion : history tachyarrhythmias , seizure , coagulopathy ( international normalize ratio &gt; 1.5 take warfarin ) , hypothyroidism . Study investigator research nurse recruit participant ; write , informed consent sign patient guardian . The treatment group receive aminophylline 5 mg/kg IV load 30 minute , follow 0.5 mg/kg IV every hour , 72 hour .The control group receive placebo bolus follow IV infusion normal saline ( 0.9 % ) every hour ( matched volume appearance treatment group ) , 72 hour .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Patients acute injury ( AKI ) lack circulate volume ( central venous pressure &gt; 8cmH2O ) Patients chronic kidney disease Patients acute renal injury cause insufficient circulating volume Patients cooperate use drug therapy Patients cooperate relevant examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>